Table 1.
Percent of patients with aNSCLC with NGS test dates prior to 60 days and prior to 1 year after the advanced diagnosisa date, by year of advanced diagnosis.
| Year of advanced diagnosis | n | % patients tested within 60 days of advanced diagnosisa | % patients tested within 1 year of advanced diagnosisa |
|---|---|---|---|
| 2011 | 3,545 | 0.08 | 0.14 |
| 2012 | 4,867 | 0.43 | 1.50 |
| 2013 | 5,911 | 2.76 | 4.75 |
| 2014 | 6,676 | 5.77 | 8.42 |
| 2015 | 6,874 | 12.92 | 17.08 |
| 2016 | 7,065 | 18.13 | 23.03 |
| 2017 | 7,103 | 26.71 | 31.24 |
| 2018 | 6,523 | 35.80 | NA |
aAdvanced NSCLC diagnosis refers to the diagnosis of stage IIIB or IV disease, or the diagnosis of a recurrence (progression) of initial early-stage disease; this differs from the initial diagnosis, which refers to the earliest diagnosis for NSCLC, regardless of stage at that moment.